HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

European Union BSE cosmetics tallow exemption expected by March -- COLIPA conference.

This article was originally published in The Rose Sheet

Executive Summary

EUROPEAN UNION BSE TALLOW EXEMPTION FOR COSMETICS ANTICIPATED IN MARCH when the European Commission is expected to decide on the proposal granting a derogation for tallow derivatives used in cosmetics and pharmaceuticals from the Jan. 1 European Union ban on the use of all transmissible spongiform encephalopathies (TSEs) specified risk materials (SRMs), according to the Commission's Directorate General III Pharmaceutical and Cosmetics Unit. Speaking at the European Cosmetic, Toiletry and Perfumery Association (COLIPA) Information Day in Brussels Feb. 4, DG III Administrator Lee Bansil said the exemption, which would be presented to the Commission "in the coming days," would carve out tallow from the ban when processed using appropriate methods designated by the Scientific Committee on Cosmetic Products and Non-Food Products (SCCNFP).
Advertisement
Advertisement
UsernamePublicRestriction

Register

RS005117

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel